IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 247 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $121,768 | -53.5% | 18,676 | -37.9% | 0.02% | -48.5% |
| Q1 2024 | $262,093 | +26.8% | 30,091 | +66.6% | 0.03% | -17.5% |
| Q4 2023 | $206,618 | +436.8% | 18,061 | +351.9% | 0.04% | +263.6% |
| Q3 2023 | $38,491 | +77.7% | 3,997 | +96.3% | 0.01% | +57.1% |
| Q2 2023 | $21,663 | -1.4% | 2,036 | -2.5% | 0.01% | 0.0% |
| Q1 2023 | $21,976 | +13.8% | 2,089 | +34.1% | 0.01% | -12.5% |
| Q4 2022 | $19,304 | +28.7% | 1,558 | +8.6% | 0.01% | +33.3% |
| Q3 2022 | $15,000 | – | 1,435 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $191,107,000 | 16.54% |
| HealthInvest Partners AB | 730,000 | $8,512,000 | 11.99% |
| 13D Management LLC | 612,853 | $7,146,000 | 2.74% |
| Brown Capital Management | 16,257,899 | $189,567,000 | 1.57% |
| BRIDGER MANAGEMENT, LLC | 929,714 | $10,840,000 | 1.40% |
| Camber Capital Management LP | 3,000,000 | $34,980,000 | 1.20% |
| Intrinsic Value Partners, LLC | 55,057 | $642,000 | 0.68% |
| PRICE MICHAEL F | 520,000 | $6,063,000 | 0.67% |
| CLARK ESTATES INC/NY | 355,000 | $4,139,000 | 0.61% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8,145,674 | $94,979,000 | 0.56% |